FACTORS AFFECTING EFFICACY OF GASTROESOPHAGEAL REFLUX DISEASE TREATMENT WITH PROTON PUMP INHIBITORS

被引：0
|
作者：
Lazebnik, L. B. [1 ]
Bordin, D. S. [1 ]
Masharova, A. A. [1 ]
Firsova, L. D. [1 ]
Silvestrova, S. Yu. [1 ]
机构：
[1] Cent Sci Res Inst Gastroenterol, Moscow 111123, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2012年 / 84卷 / 02期
关键词：
gastroesophageal reflux disease; quality of life; mental status; PPIs pharmacokinetics; SYMPTOMS; THERAPY; PATIENT;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim. The aim of the study was to determine causes of proton pump inhibitors. (PPIs) inefficacy in some patients suffering from gastroesophageal reflux disease (GERD). Material and methods. In our study of 154 GERD patients, 50 received omeprazole. 51 - lansoprazole and 53 - pantoprazole in a standard daily dose. GERD symptoms (heartburn and regurgitation) were scored by Likert scale: the patients' quality of life (SF-36) and their mental status (SMALL) were examined. Upper gastrointestinal endoscopy. 24-h intraesophageal pH monitoring, esophageal manometry and pharmacokinetic study were performed. Results. The treatment with a standard dose of PPIs was ineffective in 21 (13.6%) patients. Causes of PPIs inefficacy in 4.5% patients were rapid PPI metabolism and in 9.1% - "driving gear" of symptoms formation related with psychic dysadaptation.
引用
收藏
页码：16 / 21
页数：6
相关论文
共 50 条
  • [21] Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors
    Johnson, David A.
    Levy, Benjamin H., III
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (09) : 1541 - 1548
  • [22] Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Reply
    Chu, Michael P.
    Sawyer, Michael B.
    JAMA ONCOLOGY, 2018, 4 (02) : 265 - 265
  • [23] Factors Associated With Persistent Use of Proton Pump Inhibitors Among Patients With Gastroesophageal Reflux Disease
    Rane, Pratik P.
    Guha, Sushovan
    Aparasu, Rajender
    GASTROENTEROLOGY, 2016, 150 (04) : S240 - S240
  • [24] The use of proton pump inhibitors as a diagnostic test for gastroesophageal reflux disease
    Numans, ME
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (02) : 247 - 248
  • [25] Gastroesophageal reflux disease management and chronic use of proton pump inhibitors
    Howland, Anne M.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (12):
  • [26] Effectiveness and Safety of Proton Pump Inhibitors in Infantile Gastroesophageal Reflux Disease
    Higginbotham, Tanner W.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 572 - 576
  • [27] Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
    Shi, Yi-Chao
    Cai, Shun-Tian
    Tian, Ya-Ping
    Zhao, Hui-Jun
    Zhang, Yan-Bing
    Chen, Jing
    Ren, Rong-Rong
    Luo, Xi
    Peng, Li-Hua
    Sun, Gang
    Yang, Yun-Sheng
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2019, 17 (01) : 52 - 63
  • [28] Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
    Yi-Chao Shi
    Shun-Tian Cai
    Ya-Ping Tian
    Hui-Jun Zhao
    Yan-Bing Zhang
    Jing Chen
    Rong-Rong Ren
    Xi Luo
    Li-Hua Peng
    Gang Sun
    Yun-Sheng Yang
    Genomics,Proteomics & Bioinformatics, 2019, (01) : 52 - 63
  • [29] Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors
    Shibli F.
    Kitayama Y.
    Fass R.
    Current Gastroenterology Reports, 2020, 22 (4)
  • [30] Are proton pump inhibitors indicated for the treatment of gastroesophageal reflux in infants and children?
    Rudolph, CD
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 : S60 - S64
12345